首页> 外文期刊>Journal of evaluation in clinical practice >Is the SF-12 version 2 health survey a valid and equivalent substitute for the SF-36 version 2 health survey for the chinese?
【24h】

Is the SF-12 version 2 health survey a valid and equivalent substitute for the SF-36 version 2 health survey for the chinese?

机译:SF-12第2版健康检查是否有效替代了SF-36第2版健康检查?

获取原文
获取原文并翻译 | 示例
           

摘要

Rationale and objectives The scoring algorithm of the 12-item Short-Form Health Survey (SF-12) was revised in the second version (SF-12v2), but information on its psychometric properties is lacking. This study determined whether the SF-12v2 was a valid and equivalent substitute for the SF-36v2 Health Survey (version 2) for the Chinese. Methods A total of 2410 Chinese adults in Hong Kong completed the SF-36 Health Survey by telephone. The SF-12v2 data were extracted from the SF-36 data. Internal consistency was assessed by Cronbach's alpha, and test-retest reliabilities were evaluated by intraclass correlation. Criterion validity and equivalence were assessed using the SF-36v2 scores as a gold standard. Construct validity and sensitivity were assessed by known-group comparison. Results Internal consistency and test-retest reliabilities were good (range 0.67-0.82) for all except three scales. The SF-12v2 summary scores explained >80% of the total variances of the SF-36v2 summary scores. Construct validity and sensitivity were confirmed by significantly lower SF-12v2 scores in people with chronic diseases than those without. Effect size differences were less than 0.3 and relative validities were greater than 0.7 between SF-12v2 and SF-36v2 scores for different groups. Conclusion The SF-12v2 was valid, reliable and sensitive for the Chinese. It is an equivalent substitute for the SF-36v2 for the summary scales.
机译:基本原理和目标在第二版(SF-12v2)中对12项简短形式健康调查(SF-12)的计分算法进行了修订,但缺乏有关其心理计量特性的信息。这项研究确定了SF-12v2是否可以有效替代中国人的SF-36v2健康调查(第2版)。方法在香港,共有2410名中国成年人通过电话完成了SF-36健康调查。 SF-12v2数据是从SF-36数据中提取的。内部一致性通过Cronbach的alpha评估,而重测可靠性通过类内相关性评估。使用SF-36v2分数作为金标准评估标准的有效性和等效性。通过已知组比较评估构建体的有效性和敏感性。结果除三个量表外,所有数据的内部一致性和重测信度均良好(范围为0.67-0.82)。 SF-12v2汇总分数解释了SF-36v2汇总分数的总方差的80%以上。慢性病患者的SF-12v2评分显着低于非慢性病患者,从而证实了构建体的有效性和敏感性。不同组的SF-12v2和SF-36v2评分之间的效果大小差异小于0.3,相对有效性大于0.7。结论SF-12v2对中国人是有效,可靠和敏感的。它是摘要表的SF-36v2的等效替代品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号